Clinical T rial Agreement - 3 Way Inv/InsVCVD ROW Protocol: VNRX-5133-201Clinical Trial Agreement • November 18th, 2020
Contract Type FiledNovember 18th, 2020Billcode 8333848 Clinical Trial Agreem ent Sm louva o klinickém hodnocení Thls Agreement is made by and between Tuto smlouvu uzavírá (1) Covance lne., a company located at 206 Camegie Center, Princeton, New Jersey, 08450, USA and its affiliates (“Covance”) acting for and on behalf of VenatoRx Pharmaceuticals lne., located at 30 Spring Mildrive, Malvem PA,19355, US (“Sponsor”); and (1) Covance lne., společnost se sídlem 206 Camegie Center, Princeton, New Jersey, 08450, USA a její přidružené společnosti („Covance”) jednající jménem společnosti VenatoRx Pharmaceuticals lne. se sídlem 30 Spring Mildrive, Malvem PA, 19355, USA (dále jako„zadavatel"); a (2) Oblastní nemocnice Kladno, a.s., nemocnice Středočeského kraje whose principál plače of business is Vančurova 1548, 272 59 Kladno, Czech Republic, represented by Ing Jaromír Bureš, Chairman of the Board and Ing. Michal Feix, Deputy Chairman of the Board (“Institutům”); and (2) Oblastní nemocnice Kladno, a.s., nemocnice Středočeského kra